159 related articles for article (PubMed ID: 30376108)
1. Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial.
Tan DHS; Raboud JM; Szadkowski L; Grinsztejn B; Madruga JV; Figueroa MI; Cahn P; Barton SE; Clarke A; Fox J; Zubyk W; Walmsley SL;
J Antimicrob Chemother; 2019 Feb; 74(2):480-488. PubMed ID: 30376108
[TBL] [Abstract][Full Text] [Related]
2. Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial.
Agwu AL; Warshaw MG; McFarland EJ; Siberry GK; Melvin AJ; Wiznia AA; Fairlie L; Boyd S; Harding P; Spiegel HML; Abrams EJ; Carey VJ;
PLoS One; 2017; 12(6):e0178075. PubMed ID: 28604824
[TBL] [Abstract][Full Text] [Related]
3. Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial.
Reynolds SJ; Makumbi F; Newell K; Kiwanuka N; Ssebbowa P; Mondo G; Boaz I; Wawer MJ; Gray RH; Serwadda D; Quinn TC
Lancet Infect Dis; 2012 Jun; 12(6):441-8. PubMed ID: 22433279
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.
Kunisaki KM; Niewoehner DE; Collins G; Aagaard B; Atako NB; Bakowska E; Clarke A; Corbelli GM; Ekong E; Emery S; Finley EB; Florence E; Infante RM; Kityo CM; Madero JS; Nixon DE; Tedaldi E; Vestbo J; Wood R; Connett JE;
Lancet Respir Med; 2016 Dec; 4(12):980-989. PubMed ID: 27773665
[TBL] [Abstract][Full Text] [Related]
5. Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial.
Tan DH; Raboud JM; Kaul R; Grinsztejn B; Cahn P; Walmsley SL
Trials; 2010 Nov; 11():113. PubMed ID: 21106086
[TBL] [Abstract][Full Text] [Related]
6. Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand.
Jourdain G; Le Cœur S; Ngo-Giang-Huong N; Traisathit P; Cressey TR; Fregonese F; Leurent B; Collins IJ; Techapornroong M; Banchongkit S; Buranabanjasatean S; Halue G; Nilmanat A; Luekamlung N; Klinbuayaem V; Chutanunta A; Kantipong P; Bowonwatanuwong C; Lertkoonalak R; Leenasirimakul P; Tansuphasawasdikul S; Sang-A-Gad P; Pathipvanich P; Thongbuaban S; Wittayapraparat P; Eiamsirikit N; Buranawanitchakorn Y; Yutthakasemsunt N; Winiyakul N; Decker L; Barbier S; Koetsawang S; Sirirungsi W; McIntosh K; Thanprasertsuk S; Lallemant M;
PLoS Med; 2013 Aug; 10(8):e1001494. PubMed ID: 23940461
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
AIDS; 1998 Mar; 12(4):F1-8. PubMed ID: 9520161
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3.
Currier JS; Britto P; Hoffman RM; Brummel S; Masheto G; Joao E; Santos B; Aurpibul L; Losso M; Pierre MF; Weinberg A; Gnanashanmugam D; Chakhtoura N; Klingman K; Browning R; Coletti A; Mofenson L; Shapiro D; Pilotto J;
PLoS One; 2017; 12(5):e0176009. PubMed ID: 28489856
[TBL] [Abstract][Full Text] [Related]
9. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
Moyle GJ; Bouza E; Antunes F; Smith D; Harris R; Warburg M; Walker M
Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442
[TBL] [Abstract][Full Text] [Related]
10. CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study.
Wittkop L; Arsandaux J; Trevino A; Schim van der Loeff M; Anderson J; van Sighem A; Böni J; Brun-Vezinet F; Soriano V; Boufassa F; Brockmeyer N; Calmy A; Dabis F; Jarrin I; Dorrucci M; Duque V; Fätkenheuer G; Zangerle R; Ferrer E; Porter K; Judd A; Sipsas NV; Lambotte O; Shepherd L; Leport C; Morrison C; Mussini C; Obel N; Ruelle J; Schwarze-Zander C; Sonnerborg A; Teira R; Torti C; Valadas E; Colin C; Friis-Møller N; Costagliola D; Thiebaut R; Chene G; Matheron S;
J Antimicrob Chemother; 2017 Oct; 72(10):2869-2878. PubMed ID: 29091198
[TBL] [Abstract][Full Text] [Related]
11. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
[TBL] [Abstract][Full Text] [Related]
12. CD4 and viral load dynamics in antiretroviral-naïve HIV-infected adults from Soweto, South Africa: a prospective cohort.
Martinson NA; Gupte N; Msandiwa R; Moulton LH; Barnes GL; Ram M; Gray G; Hoffmann C; Chaisson RE
PLoS One; 2014; 9(5):e96369. PubMed ID: 24831447
[TBL] [Abstract][Full Text] [Related]
13. The effects of lamivudine treatment on HIV-1 disease progression are highly correlated with plasma HIV-1 RNA and CD4 cell count.
Montaner JS; DeMasi R; Hill AM
AIDS; 1998 Mar; 12(5):F23-8. PubMed ID: 9543436
[TBL] [Abstract][Full Text] [Related]
14. Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam.
Cuong DD; Sönnerborg A; Van Tam V; El-Khatib Z; Santacatterina M; Marrone G; Chuc NT; Diwan V; Thorson A; Le NK; An PN; Larsson M
BMC Infect Dis; 2016 Dec; 16(1):759. PubMed ID: 27986077
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
Yi TJ; Walmsley S; Szadkowski L; Raboud J; Rajwans N; Shannon B; Kumar S; Kain KC; Kaul R; Tan DH
Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of nevirapine extended-release once daily versus nevirapine immediate-release twice-daily in treatment-naive HIV-1-infected patients.
Gathe J; Andrade-Villanueva J; Santiago S; Horban A; Nelson M; Cahn P; Bogner J; Spencer D; Podzamczer D; Yong CL; Nguyen T; Zhang W; Drulak M; Quinson AM
Antivir Ther; 2011; 16(5):759-69. PubMed ID: 21817198
[TBL] [Abstract][Full Text] [Related]
17. Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database.
Zhou J; Sirisanthana T; Kiertiburanakul S; Chen YM; Han N; Lim PL; Kumarasamy N; Choi JY; Merati TP; Yunihastuti E; Oka S; Kamarulzaman A; Phanuphak P; Lee CK; Li PC; Pujari S; Saphonn V; Law MG
BMC Infect Dis; 2010 Dec; 10():361. PubMed ID: 21182796
[TBL] [Abstract][Full Text] [Related]
18. Virological and immunological responses to once-daily dosing of didanosine in combination with stavudine. AI454-143 Team.
Mobley JE; Pollard RB; Schrader S; Adler MH; Kelleher T; McLaren C
AIDS; 1999 Jul; 13(11):F87-93. PubMed ID: 10449279
[TBL] [Abstract][Full Text] [Related]
19. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.
Currier JS; Williams PL; Koletar SL; Cohn SE; Murphy RL; Heald AE; Hafner R; Bassily EL; Lederman HM; Knirsch C; Benson CA; Valdez H; Aberg JA; McCutchan JA
Ann Intern Med; 2000 Oct; 133(7):493-503. PubMed ID: 11015162
[TBL] [Abstract][Full Text] [Related]
20. Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration.
Ekouévi DK; Avettand-Fènoël V; Tchounga BK; Coffie PA; Sawadogo A; Minta D; Minga A; Eholie SP; Plantier JC; Damond F; Dabis F; Rouzioux C;
PLoS One; 2015; 10(6):e0129886. PubMed ID: 26111242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
